New brain aneurysm device shows promise in 142-Patient trial

NCT ID NCT04918420

Completed Disease control Sponsor: Ton-Bridge Medical Tech. Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new medical device called the Tonbridge flow diverter to treat brain aneurysms (weak spots in blood vessels). The device is placed inside the artery to redirect blood flow away from the aneurysm, helping it heal. The trial included 142 people aged 18 to 80 with unruptured aneurysms in specific brain arteries. The main goal was to see if the aneurysm was completely blocked at 12 months after the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACRANIAL ANEURYSM

Contacts and locations

Locations

Changhai Hospital of Shanghai

Shanghai, China
Henan Provincial People's Hospital

Zhengzhou, Henan, China
Huashan Hospital Fudan University

Shanghai, China
Nanjing Drum Tower Hospital

Nanjing, Jiangsu, China
The First Affiliated Hospital of Wannan Medical College

Wuhu, Anhui, China
Xinqiao Hospital, Army Medical University

Chongqing, China
Zhejiang Hospital

Hangzhou, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.